Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01264757 · ClinicalTrials.gov registry record · Early Phase 1
Steps Toward Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population
A Early Phase 1 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 43
- Enrollment target
NCT01264757: Completed Early Phase 1 study, sponsored by Pennington Biomedical Research Center.
NCT01264757 is a Early Phase 1 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 43 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (19% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01264757, a Early Phase 1 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 43 participants
- Enrollment target
Study Summary
This feasibility study specifically addresses the issue of adapting US dietary guidelines physical activity recommendations to the population of the Lower Mississippi Delta. The hypothesis is that including a pedometer as a self-monitoring tool as part of adapted physical activity guidelines will result in greater immediate increases in physical activity (as monitored by an accelerometer) than an education program alone.
Primary Outcome
A GT3X accelerometer is used to monitor each participants physical activity levels for seven consecutive days at baseline and again following a 7-day intervention period. The amount of time per day spent above a threshold of 2200 accelerometer counts/min is averaged over at least three days as the measure of MVPA.
Interventions
- BEHAVIORAL Pedometer
- BEHAVIORAL Physical Activity Educational Materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-06 |
| Phase | Early Phase 1 |
What the finished NCT01264757 record still lists
NCT01264757 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (19% lower).
The record links to 0 conditions, and to 2 interventions - of which Pedometer is the first listed.
NCT01264757 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01264757 about?
NCT01264757 is a clinical study titled "Steps Toward Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population". This feasibility study specifically addresses the issue of adapting US dietary guidelines physical activity recommendations to the population of the Lower Mississippi Delta. The hypothesis is that including a pedometer as a self-monitoring tool as part of adapted physical activity guidelines will re...
What is the current status of trial NCT01264757?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 43 participants. The study started on 2010-02. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01264757?
The interventions under investigation include: Pedometer (BEHAVIORAL), Physical Activity Educational Materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT01264757?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01264757's enrollment target sits among peer trials
43 600th of 2000 higher than 1,397 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia